|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 04/02/15 | AbbVie : Merck says hepatitis C drugs to lose breakthrough status | RE |
| 10/06/14 | Apple : Wall St. edges up, lifted by mergers, acquisitions | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +3.78% | +5.37% | +24.26% | +33.40% | +8.94% | +47.06% | +3.50% | +28.25% | +107.97% | 83.96B | |
| +2.84% | +24.49% | +39.63% | +73.86% | -0.84% | -22.44% | -35.85% | -44.07% | +58.96% | 56.76B | |
| +0.85% | -0.32% | +10.60% | +14.71% | -8.91% | -1.93% | +30.25% | +3.00% | - | 51.35B | |
| -0.37% | -1.00% | -8.87% | -9.09% | -9.09% | +11.12% | +166.13% | +119.05% | +197.12% | 48.41B | |
| +4.24% | +6.08% | +7.56% | +16.27% | +25.89% | +59.56% | -15.16% | -34.57% | -30.07% | 32.74B | |
| +176.97% | +173.88% | +182.08% | +281.41% | +491.32% | +524.79% | +71.60% | -53.56% | - | 69.62B | |
| +4.05% | +6.38% | +9.57% | +34.38% | +30.07% | +50.33% | +100.61% | +72.42% | +68.80% | 26.04B | |
| +3.00% | +6.36% | +9.41% | +27.46% | +32.72% | +6.92% | +224.88% | +61.15% | - | 21.81B | |
| -1.80% | +2.05% | -1.12% | +4.90% | +37.56% | +61.08% | +123.10% | +155.26% | +357.34% | 17.11B | |
| +1.17% | +0.13% | +3.16% | +27.20% | +9.75% | +71.64% | +192.31% | +78.31% | - | 16.41B | |
| +1.85% | -4.41% | +42.69% | +7.65% | -12.22% | -7.60% | +793.66% | +529.60% | +6,191.83% | 15.2B | |
| +3.49% | -1.30% | +16.35% | +39.19% | +16.66% | +20.97% | -22.14% | -7.28% | -24.63% | 13.42B | |
| +1.16% | +1.65% | -5.13% | -3.74% | +19.47% | +96.06% | +208.28% | +995.93% | +2,793.90% | 11.43B | |
| +3.16% | +3.15% | -3.25% | +17.06% | +39.26% | +138.50% | +187.55% | +560.14% | - | 10.16B | |
| +22.64% | +13.72% | +51.72% | +187.66% | +348.90% | +416.28% | +631.71% | +46.24% | - | 8.93B | |
| -1.02% | -1.66% | +6.01% | +4.37% | -6.71% | -18.78% | -25.51% | -53.25% | -48.81% | 7.11B | |
| -2.81% | +0.41% | +6.60% | +5.76% | +14.35% | +25.92% | +267.43% | +256.47% | - | 6.25B | |
| -1.90% | -7.77% | +10.78% | +30.12% | +4.60% | +4.66% | +72.15% | -9.96% | - | 6.3B | |
| +1.65% | +3.39% | +26.35% | +51.48% | +95.88% | +143.74% | +380.38% | +592.97% | - | 6.3B | |
| Average | +2.03% | +11.68% | +22.55% | +44.42% | +59.87% | +85.68% | +176.57% | +173.48% | +967.24% | 25.47B | |
| Weighted average by Cap. | +1.14% | +27.74% | +38.03% | +63.79% | +81.69% | +103.35% | +100.46% | +75.45% | +494.11% |
- Stock Market
- Stocks
- Stock
- Sector Idenix Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
